ADIM
DAVA icon

Alpha DNA Investment Management’s Endava DAVA Stock Holding History

Alpha DNA Investment Management’s Portfolio DAVA Stock Details DAVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-8,927
Closed -$1.19M – 128
2022
Q1 		$1.19M Buy
+8,927
New +$1.12M 0.83% 75

Other funds holding DAVA

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Alpha DNA Investment Management's DAVA Position: Q2 2022 in Review

Alpha DNA Investment Management sold out of Endava (DAVA) in Q2 2022, closing a stake of 8,927 shares — an estimated $1.19M sold.

Alpha DNA Investment Management first reported a position in DAVA in Q1 2022 and held it in 1 quarter. The position peaked at $1.19M in Q1 2022. 185 funds tracked by Wall St. Rank hold DAVA as of Q2 2022.

  • Alpha DNA Investment Management reported no remaining Endava position as of Q2 2022 after selling out during the quarter.
  • Alpha DNA Investment Management sold 8,927 Endava shares in Q2 2022, an estimated $1.19M.
  • Alpha DNA Investment Management first reported a position in Endava in Q1 2022 and held it in 1 quarter.
  • Alpha DNA Investment Management's Endava position peaked at $1.19M in Q1 2022.
  • 185 funds tracked by Wall St. Rank held Endava as of Q2 2022.

Based on Alpha DNA Investment Management's 13F filing for Q2 2022, filed 11 Aug 2022.